The preoperative erythrocyte sedimentation rate is an independent prognostic factor in renal cell carcinoma-Reference-Cited by-同舟云学术

The preoperative erythrocyte sedimentation rate is an independent prognostic factor in renal cell carcinoma

Published:2006 Issue:2 Volume:106 Page:304-312
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Sengupta Shomik,Lohse Christine M.,Cheville John C.,Leibovich Bradley C.,Thompson R. Houston,Webster W. Scott,Frank Igor,Zincke Horst,Blute Michael L.,Kwon Eugene D.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference36 articles.

1. Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma

2. A Multifactorial Postoperative Surveillance Model for Patients With Surgically Treated Clear Cell Renal Cell Carcinoma

3. Survival and Prognostic Stratification of 670 Patients With Advanced Renal Cell Carcinoma

4. Current prognostic factors-renal cell carcinoma

5. A POSTOPERATIVE PROGNOSTIC NOMOGRAM PREDICTING RECURRENCE FOR PATIENTS WITH CONVENTIONAL CLEAR CELL RENAL CELL CARCINOMA

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The burden and predictors of venous thromboembolic diseases in patients with multiple primary malignancies;Cancer Reports;2022-10-31

2. Early Recognition and Discrimination of COVID-19 Severity Using Slime Mould Support Vector Machine for Medical Decision-Making;IEEE Access;2021

3. Combination of preoperative fibrinogen concentration and neutrophil‑to‑lymphocyte ratio for prediction of the prognosis of patients with resectable breast cancer;Oncology Letters;2020-09-04

4. Prognostic role of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with midgut neuroendocrine tumors undergoing resective surgery;International Journal of Colorectal Disease;2019-09-13

5. The pretreatment erythrocyte sedimentation rate predicts survival outcomes after surgery and adjuvant radiotherapy for extremity soft tissue sarcoma;Radiation Oncology;2019-07-04